24-MAG LLC is seeking experienced biotech investment professionals for a part-time, fully remote consultancy in the US market. The role involves evaluating commercial drugs, drug-development programmes, and company fundamentals, using structured rubrics and expert judgement.
Ideal candidates bring 5+ years of biotech investment analysis experience, proficiency in assessing MOA, data, and market opportunities, and the ability to critique investment theses across ~5–10 companies during a pilot.
#J-18808-LjbffrRemote Part-Time Biotech Investment Analyst: Asset Valuation in new york at Unknown Company
This position is listed as part time and able to be worked remotely.